Meghmani Organics Q1 FY27 earnings call

Meghmani Organics Limited faced a challenging Q1 FY27, with consolidated revenue declining by 12% year-on-year to INR542 crores. This was attributed to softer demand in key export and domestic markets, leading to cautious customer buying behavior. Despite the revenue decline, the company demonstrated strong profitability improvements, with consolidated net profit growing by 280% to INR48.2 crores and consolidated EBITDA increasing by 46% to INR97.9 crores. The consolidated EBITDA margin expanded significantly to 18% from 10.9% in the corresponding quarter of the previous year, driven by product mix optimization, disciplined pricing, and operational efficiencies.

The Crop Protection segment contributed approximately 75% of total revenue, reporting INR391 crores in revenue and INR77.8 crores in EBITDA, with an EBITDA margin of 19.9%. Capacity utilization for this segment stood at 63%. The Pigment segment generated INR131 crores in revenue and INR15.9 crores in EBITDA, achieving a 12.1% EBITDA margin, but with a lower capacity utilization of 39%. Management indicated a focus on profitability over full utilization in the Pigment segment, targeting an annualized revenue of INR500-600 crores and an EBITDA margin near 10%.

The Crop Nutrition segment delivered a positive contribution to both revenue and profitability. Building on the success of Nano Urea, the company has expanded its product offering with new nano fertilizer products, including Nano DAP, Nano NPK, and Nano Zinc. Management expressed optimism for this segment, projecting a revenue contribution of 'a couple of INR100 crores' over the next two to three years, driven by ongoing developmental activities in India and globally.

The Titanium Dioxide operation remained suspended in Q1 FY27 due to commercial unviability. This was primarily caused by elevated raw material costs, particularly sulfur, which saw an 8-10 times price increase due to global macroeconomic factors and war conditions, combined with weaker price realization following the withdrawal of anti-dumping duty. The suspension resulted in a negative EBITDA of nearly INR3 crores for the segment in Q1 FY27, with management indicating annual losses of INR10-12 crores if operations were to continue.

The company's consolidated total debt stood at INR732 crores as of June 30, 2026, with a debt-to-equity ratio of 0.46. Meghmani Organics repaid approximately INR32 crores of debt in Q1 FY27. Management plans to repay around INR130 crores this fiscal year, with an average cost of debt around 7%. The substantial reduction in finance costs was attributed to a shift towards INR-denominated debt, which mitigated foreign currency volatility^🌐 and mark-to-market losses, alongside the ongoing debt reduction efforts.

The company is proceeding with the amalgamation of two wholly-owned subsidiaries. The scheme was filed in April, and a second motion application has been submitted after receiving approval from secured and unsecured creditors. This internal restructuring is expected to generate synergies through cost reduction and improved operational discipline, contributing to overall profitability and compliance. The accounting treatment will follow the pooling of interest method, integrating all line items into Meghmani Organics Limited.